127 related articles for article (PubMed ID: 37972293)
1. Clinical Efficacy of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations.
Endrikat J; Gutberlet M; Barkhausen J; Schöckel L; Bhatti A; Harz C; Hoffmann KT
Invest Radiol; 2024 May; 59(5):345-358. PubMed ID: 37972293
[TBL] [Abstract][Full Text] [Related]
2. Clinical Safety of Gadobutrol: Review of Over 25 Years of Use Exceeding 100 Million Administrations.
Endrikat J; Gutberlet M; Hoffmann KT; Schöckel L; Bhatti A; Harz C; Barkhausen J
Invest Radiol; 2024 Mar; ():. PubMed ID: 38426761
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of gadobutrol-enhanced MRA of the renal arteries: Results from GRAMS (Gadobutrol-enhanced renal artery MRA study), a prospective, intraindividual multicenter phase 3 blinded study.
Fabrega-Foster KE; Agarwal S; Rastegar N; Haverstock D; Agris JM; Kamel IR
J Magn Reson Imaging; 2018 Feb; 47(2):572-581. PubMed ID: 28574637
[TBL] [Abstract][Full Text] [Related]
4. Clinical Efficacy of Reduced-Dose Gadobutrol Versus Standard-Dose Gadoterate for Contrast-Enhanced MRI of the CNS: An International Multicenter Prospective Crossover Trial (LEADER-75).
Liu BP; Rosenberg M; Saverio P; Weon YC; Peters S; Ardellier FD; Boeckenhoff A; Endrikat J
AJR Am J Roentgenol; 2021 Nov; 217(5):1195-1205. PubMed ID: 34133205
[No Abstract] [Full Text] [Related]
5. Intraindividual quantitative and qualitative comparison of gadopentetate dimeglumine and gadobutrol in time-resolved contrast-enhanced 4-dimensional magnetic resonance angiography in minipigs.
Hadizadeh DR; Jost G; Pietsch H; Weibrecht M; Perkuhn M; Boschewitz JM; Keil VC; Träber F; Kukuk GM; Schild HH; Willinek WA
Invest Radiol; 2014 Jul; 49(7):457-64. PubMed ID: 24598442
[TBL] [Abstract][Full Text] [Related]
6. Dynamic and static magnetic resonance angiography of the supra-aortic vessels at 3.0 T: intraindividual comparison of gadobutrol, gadobenate dimeglumine, and gadoterate meglumine at equimolar dose.
Kramer JH; Arnoldi E; François CJ; Wentland AL; Nikolaou K; Wintersperger BJ; Grist TM
Invest Radiol; 2013 Mar; 48(3):121-8. PubMed ID: 23211552
[TBL] [Abstract][Full Text] [Related]
7. Improved display of abdominal contrast-enhanced MRA using gadobutrol: comparison with Gd-DTPA.
Liu X; Zhang W; Li Z; Fu Y; Ren J; Shen W; Wang J; Xu Y; Song B
Clin Radiol; 2019 Dec; 74(12):978.e1-978.e7. PubMed ID: 31551147
[TBL] [Abstract][Full Text] [Related]
8. Gadobutrol Precedes Gd-DTPA in Abdominal Contrast-Enhanced MRA and MRI: A Prospective, Multicenter, Intraindividual Study.
Liu X; Li Z; Zhang W; Yang C; Diao Y; Duan T; Fu Y; Ren J; Bin S
Contrast Media Mol Imaging; 2019; 2019():9738464. PubMed ID: 31866800
[TBL] [Abstract][Full Text] [Related]
9. Gadobutrol: A Review in Contrast-Enhanced MRI and MRA.
Scott LJ
Clin Drug Investig; 2018 Aug; 38(8):773-784. PubMed ID: 30006819
[TBL] [Abstract][Full Text] [Related]
10. A Japanese, Multicenter, Open-label, Phase 3 Study to Investigate the Safety and Efficacy of Gadobutrol for Contrast-enhanced MR Imaging of the Central Nervous System.
Tanaka A; Masumoto T; Yamada H; Kurauchi M; Breuer J
Magn Reson Med Sci; 2016; 15(2):227-36. PubMed ID: 26687097
[TBL] [Abstract][Full Text] [Related]
11. MR Angiography at 3 T of Peripheral Arterial Disease: A Randomized Prospective Comparison of Gadoterate Meglumine and Gadobutrol.
Loewe C; Arnaiz J; Krause D; Marti-Bonmati L; Haneder S; Kramer U;
AJR Am J Roentgenol; 2015 Jun; 204(6):1311-21. PubMed ID: 26001243
[TBL] [Abstract][Full Text] [Related]
12. A clinical combined gadobutrol bolus and slow infusion protocol enabling angiography, inversion recovery whole heart, and late gadolinium enhancement imaging in a single study.
Tandon A; James L; Henningsson M; Botnar RM; Potersnak A; Greil GF; Hussain T
J Cardiovasc Magn Reson; 2016 Oct; 18(1):66. PubMed ID: 27716273
[TBL] [Abstract][Full Text] [Related]
13. Safety of gadobutrol in over 23,000 patients: the GARDIAN study, a global multicentre, prospective, non-interventional study.
Prince MR; Lee HG; Lee CH; Youn SW; Lee IH; Yoon W; Yang B; Wang H; Wang J; Shih TT; Huang GS; Lirng JF; Palkowitsch P;
Eur Radiol; 2017 Jan; 27(1):286-295. PubMed ID: 26960538
[TBL] [Abstract][Full Text] [Related]
14. Peripheral magnetic resonance angiography with continuous table movement in combination with high spatial and temporal resolution time-resolved MRA With a total single dose (0.1 mmol/kg) of gadobutrol at 3.0 T.
Voth M; Haneder S; Huck K; Gutfleisch A; Schönberg SO; Michaely HJ
Invest Radiol; 2009 Sep; 44(9):627-33. PubMed ID: 19652610
[TBL] [Abstract][Full Text] [Related]
15. Gadobutrol in India-A Comprehensive Review of Safety and Efficacy.
Endrikat J; Anzalone N
Magn Reson Insights; 2017; 10():1178623X17730048. PubMed ID: 28932122
[TBL] [Abstract][Full Text] [Related]
16. Phase 3 efficacy and safety trial of gadobutrol, a 1.0 molar macrocyclic MR imaging contrast agent, in patients referred for contrast-enhanced MR imaging of the central nervous system.
Gutierrez JE; Rosenberg M; Duhaney M; Simon JA; Brueggenwerth G; Agris JM; Knopp EA
J Magn Reson Imaging; 2015 Mar; 41(3):788-96. PubMed ID: 24578298
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and safety of gadobutrol-enhanced magnetic resonance imaging in pediatric patients.
Hahn G; Sorge I; Gruhn B; Glutig K; Hirsch W; Bhargava R; Furtner J; Born M; Schröder C; Ahlström H; Kaiser S; Moritz JD; Kunze CW; Shroff M; Stokland E; Trnkova ZJ; Schultze-Mosgau M; Reif S; Bacher-Stier C; Mentzel HJ
Invest Radiol; 2009 Dec; 44(12):776-83. PubMed ID: 19858730
[TBL] [Abstract][Full Text] [Related]
18. Gadobutrol: a review of its use for contrast-enhanced magnetic resonance imaging in adults and children.
Scott LJ
Clin Drug Investig; 2013 Apr; 33(4):303-14. PubMed ID: 23435930
[TBL] [Abstract][Full Text] [Related]
19. Safety of gadobutrol in more than 1,000 pediatric patients: subanalysis of the GARDIAN study, a global multicenter prospective non-interventional study.
Glutig K; Bhargava R; Hahn G; Hirsch W; Kunze C; Mentzel HJ; Schaefer JF; Willinek W; Palkowitsch P;
Pediatr Radiol; 2016 Aug; 46(9):1317-23. PubMed ID: 27041276
[TBL] [Abstract][Full Text] [Related]
20. Safety of contrast-enhanced MR angiography employing gadobutrol 1.0 M as contrast material.
Balzer JO; Loewe C; Davis K; Goyen M; Leiner T; Meaney JF; Pöckler-Schöniger C; Schulte-Altedorneburg G; Tombach B; Vosshenrich R; Wegener R
Eur Radiol; 2003 Sep; 13(9):2067-74. PubMed ID: 12928957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
